Cargando…
Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus: A Case Report
The incidence of left ventricular (LV) thrombi in the setting of an anterior myocardial infarction has declined significantly since the advent of primary percutaneous coronary intervention coupled with contemporary antithrombotic strategies in ST-segment elevation myocardial infarctions (STE-ACS). D...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433551/ https://www.ncbi.nlm.nih.gov/pubmed/28540312 http://dx.doi.org/10.1177/2324709617697991 |
_version_ | 1783236878216986624 |
---|---|
author | Seecheran, Rajeev Seecheran, Valmiki Persad, Sangeeta Seecheran, Naveen Anand |
author_facet | Seecheran, Rajeev Seecheran, Valmiki Persad, Sangeeta Seecheran, Naveen Anand |
author_sort | Seecheran, Rajeev |
collection | PubMed |
description | The incidence of left ventricular (LV) thrombi in the setting of an anterior myocardial infarction has declined significantly since the advent of primary percutaneous coronary intervention coupled with contemporary antithrombotic strategies in ST-segment elevation myocardial infarctions (STE-ACS). Despite oral anticoagulation with the currently accepted, standard-of-care vitamin K antagonist, warfarin, major bleeding complications still arise. Rivaroxaban is a novel, direct oral factor X anticoagulant that has several advantageous properties, which can attenuate bleeding risk. We present a case in which a patient successfully underwent a 3-month course of rivaroxaban in addition to his dual antiplatelet regimen of aspirin and ticagrelor for his STE-ACS and LV thrombus with resultant complete dissolution. |
format | Online Article Text |
id | pubmed-5433551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-54335512017-05-24 Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus: A Case Report Seecheran, Rajeev Seecheran, Valmiki Persad, Sangeeta Seecheran, Naveen Anand J Investig Med High Impact Case Rep Case Report The incidence of left ventricular (LV) thrombi in the setting of an anterior myocardial infarction has declined significantly since the advent of primary percutaneous coronary intervention coupled with contemporary antithrombotic strategies in ST-segment elevation myocardial infarctions (STE-ACS). Despite oral anticoagulation with the currently accepted, standard-of-care vitamin K antagonist, warfarin, major bleeding complications still arise. Rivaroxaban is a novel, direct oral factor X anticoagulant that has several advantageous properties, which can attenuate bleeding risk. We present a case in which a patient successfully underwent a 3-month course of rivaroxaban in addition to his dual antiplatelet regimen of aspirin and ticagrelor for his STE-ACS and LV thrombus with resultant complete dissolution. SAGE Publications 2017-03-23 /pmc/articles/PMC5433551/ /pubmed/28540312 http://dx.doi.org/10.1177/2324709617697991 Text en © 2017 American Federation for Medical Research http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution 3.0 License (http://www.creativecommons.org/licenses/by/3.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Seecheran, Rajeev Seecheran, Valmiki Persad, Sangeeta Seecheran, Naveen Anand Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus: A Case Report |
title | Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus: A Case Report |
title_full | Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus: A Case Report |
title_fullStr | Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus: A Case Report |
title_full_unstemmed | Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus: A Case Report |
title_short | Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus: A Case Report |
title_sort | rivaroxaban as an antithrombotic agent in a patient with st-segment elevation myocardial infarction and left ventricular thrombus: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433551/ https://www.ncbi.nlm.nih.gov/pubmed/28540312 http://dx.doi.org/10.1177/2324709617697991 |
work_keys_str_mv | AT seecheranrajeev rivaroxabanasanantithromboticagentinapatientwithstsegmentelevationmyocardialinfarctionandleftventricularthrombusacasereport AT seecheranvalmiki rivaroxabanasanantithromboticagentinapatientwithstsegmentelevationmyocardialinfarctionandleftventricularthrombusacasereport AT persadsangeeta rivaroxabanasanantithromboticagentinapatientwithstsegmentelevationmyocardialinfarctionandleftventricularthrombusacasereport AT seecherannaveenanand rivaroxabanasanantithromboticagentinapatientwithstsegmentelevationmyocardialinfarctionandleftventricularthrombusacasereport |